| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Department of Molecular and Cellular Physiology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH45267-0576, U.S.A.; Departments of Epidemiology and Microbiology and Immunology and; Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599-7435, U.S.A.
* To whom correspondence should be addressed. Email:
marc.wathelet{at}uc.edu.
The severe acute respiratory syndrome (SARS) epidemic was caused by the spread of a previously unrecognized infectious agent, the SARS-associated coronavirus (SARS-CoV). Here we show that SARS-CoV could inhibit both virus- and interferon (IFN)-dependent signaling, two key steps of the antiviral response. We mapped a strong inhibitory activity to SARS-CoV non-structural protein 1 (nsp1) and show that expression of nsp1 significantly inhibited the activation of all three virus-dependent signaling pathways. We show that expression of nsp1 significantly inhibited IFN-dependent signaling by decreasing the phosphorylation levels of STAT1, while having little effect on those of STAT2, JAK1 and TYK2. We engineered an attenuated mutant of nsp1 in SARS-CoV through reverse genetics and the resulting mutant virus was viable and replicated as efficiently as wild type virus in cells with a defective IFN response. However, the mutant virus replication was strongly attenuated in cells with an intact IFN response. Thus, nsp1 is likely a virulence factor that would contribute to pathogenicity by favoring SARS-CoV replication.
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
The SARS coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain
![]()
Abstract
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|